Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
Status: | Recruiting |
---|---|
Conditions: | Alzheimer Disease, Neurology |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | Any |
Updated: | 4/2/2016 |
Start Date: | September 2014 |
Contact: | Jacob E Teitelbaum, MD |
Email: | endfatigue@aol.com |
Phone: | 410-562-7409 |
Effective Treatment of Alzheimer's and Dementia With the MIND Protocol
Treating with measures that may improve metabolic functioning of neurons in an integrated
protocol
protocol
Most organ failure results in modest drops in function until over 50% of function is lost.
At a certain point, even modest drops in physiologic activity result in dramatic drops in
clinical function. Though less homogeneous than in other organs, clinical experience and the
literature suggests a similar process occurs in the brain. The hypothesis is that by using
an integrated protocol to, essentially, "tune up" neuronal function, a 5-10 % improvement in
metabolic functioning may translate to significant improvement in clinical functioning. This
tune-up will include "MIND":
M- Metabolism-- optimizing hormonal function I- Infections-- looking for and eliminating N-
Nutritional and herbal support D- Drugs- Weaning subjects off unneeded medications
At a certain point, even modest drops in physiologic activity result in dramatic drops in
clinical function. Though less homogeneous than in other organs, clinical experience and the
literature suggests a similar process occurs in the brain. The hypothesis is that by using
an integrated protocol to, essentially, "tune up" neuronal function, a 5-10 % improvement in
metabolic functioning may translate to significant improvement in clinical functioning. This
tune-up will include "MIND":
M- Metabolism-- optimizing hormonal function I- Infections-- looking for and eliminating N-
Nutritional and herbal support D- Drugs- Weaning subjects off unneeded medications
Inclusion Criteria:
- A diagnosis of Alzheimer's and/or dementia with an MMSE score over 12 or being
ambulatory and able to travel outside the home with assistance.
- Must have a caregiver living with them.
Exclusion Criteria:
- Overt progressive and severe causes of secondary dementia such as metastatic brain
cancers, or severe overt infectious encephalopathies or severe autoimmune illness.
- Also, severe life threatening illnesses which would make them unlikely to be alive
after 6-12 months
We found this trial at
1
site